Keith Wan
Optometrist · San Diego, CANPI 1235181165
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 88.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $22,241 and has fallen 67.2% since, to $7,287 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $332.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$77K
- Johnson & Johnson Vision Care, Inc.$4K
- Alcon$3K
- Bausch & Lomb Americas Inc.$1K
- Tarsus Pharmaceuticals, Inc.$592
- Bausch & Lomb, A Division Of Bausch Health US, LLC$383
- plus $756 from 8 others
Across 83 payments — averaging $9905.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$651K
- Johnson & Johnson Vision Care, Inc.$120K
- Coopervision Inc.$22K
- Oyster Point Pharma, Inc.$21K
- Tarsus Pharmaceuticals, Inc.$8K
- Topcon Healthcare, Inc.$300
What the payments were for
- Consulting fees$17,44020%
- Speaking & faculty fees$46,92754%
- Travel & lodging$12,38914%
- Food & beverage$9,92511%
- Education$5001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 156 | $77,120 |
| Johnson & Johnson Vision Care, Inc. | 15 | $3,722 |
| Alcon | 45 | $3,166 |
| Bausch & Lomb Americas Inc. | 14 | $1,441 |
| Tarsus Pharmaceuticals, Inc. | 6 | $592 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $383 |
| Biotissue Holdings Inc. | 6 | $338 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Ocular Therapeutix, Inc. | 3 | $88 |
| Sight Sciences, Inc. | 4 | $69 |
| Genentech USA, Inc. | 1 | $59 |
| AbbVie(2 entities) | 2 | $35 |
| Eyevance Pharmaceuticals LLC | 1 | $24 |
| Kala Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$61,772
- MyDay Contact Lens$8,190
- INFUSE$1,132
- TOTAL30$395
- MIEBO$276
- Prokera$247
- AmnioGraft$247
- LOTEMAX SM$234
- VYZULTA$150
- Precision7$133
- XIIDRA$126
- Acuvue$125
- XDEMVY$122
- EYLEA$120
- Multiple Brands Contact Lens$100
How this compares
$87,180 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in San Diego
- Jason TuSan Diego$351K
- Alicia LauSan Diego$300K
- Melody TavakoliSan Diego$267K
- Brian ChouSan Diego$243K
- David GeffenSan Diego$144K
- Elliott ShapiroSan Diego$135K
- Jennifer ChinnSan Diego$67K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.